AU2002211176A1 - Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3 - Google Patents
Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3Info
- Publication number
- AU2002211176A1 AU2002211176A1 AU2002211176A AU1117602A AU2002211176A1 AU 2002211176 A1 AU2002211176 A1 AU 2002211176A1 AU 2002211176 A AU2002211176 A AU 2002211176A AU 1117602 A AU1117602 A AU 1117602A AU 2002211176 A1 AU2002211176 A1 AU 2002211176A1
- Authority
- AU
- Australia
- Prior art keywords
- composition
- receptor antagonists
- serotonin receptor
- serotonin
- antagonists
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US24466200P | 2000-11-01 | 2000-11-01 | |
US60244662 | 2000-11-01 | ||
SE0003996A SE0003996D0 (en) | 2000-11-01 | 2000-11-01 | receptor Antagonists |
SE0003996 | 2000-11-01 | ||
PCT/SE2001/002373 WO2002036114A1 (en) | 2000-11-01 | 2001-10-30 | Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2002211176A1 true AU2002211176A1 (en) | 2002-05-15 |
Family
ID=26655285
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2002211176A Withdrawn AU2002211176A1 (en) | 2000-11-01 | 2001-10-30 | Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3 |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2002211176A1 (en) |
WO (1) | WO2002036114A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2405594T3 (en) | 2002-09-25 | 2013-05-31 | Memory Pharmaceuticals Corporation | Idazoles, benzothiazoles and benzisothiazoles, and preparation and uses thereof |
RS20060391A (en) | 2003-12-22 | 2008-11-28 | Memory Pharmaceuticals Corporation, | Indoles, 1h-indazoles, 1,2-benzisoxazoles, and 1,2- benzisothiazoles, and preparation and uses thereof |
EP1725226A2 (en) * | 2004-03-17 | 2006-11-29 | Sosei R&D Ltd. | The treatment of inflammatory disorders and pain using beta-aminoalcohols |
CN103724343A (en) | 2004-03-25 | 2014-04-16 | 记忆药物公司 | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, and preparation and uses thereof |
US7488737B2 (en) | 2004-04-22 | 2009-02-10 | Memory Pharmaceutical Corporation | Indoles, 1H-indazoles, 1,2-benzisoxazoles, 1,2-benzoisothiazoles, and preparation and uses thereof |
DE602005027452D1 (en) | 2004-05-07 | 2011-05-26 | Memory Pharm Corp | 1H-INDAZOLE, BENZOTHIAZOLE, 1,2-BENZISOXAZOLE, 1,2-BENZISOTHIAZOLE AND CHROMONES AND THEIR PREPARATION AND USES |
WO2006029182A2 (en) * | 2004-09-07 | 2006-03-16 | The La Jolla Institute For Molecular Medicine | Use of mdl-100,907 for treatment of allergic and eosinophil mediated diseases |
JP2008525464A (en) | 2004-12-22 | 2008-07-17 | メモリー・ファーマシューティカルズ・コーポレイション | Alpha-7 nicotinic receptor ligand and its production and use |
WO2007000046A1 (en) * | 2005-06-27 | 2007-01-04 | Holburn Biomedical Corporation | Methods for diagnosing functional bowel disease |
US8106066B2 (en) | 2005-09-23 | 2012-01-31 | Memory Pharmaceuticals Corporation | Indazoles, benzothiazoles, benzoisothiazoles, benzisoxazoles, pyrazolopyridines, isothiazolopyridines, and preparation and uses thereof |
GB0901487D0 (en) * | 2009-01-30 | 2009-03-11 | Movetis N V | Asthma Therapy |
WO2014018563A2 (en) * | 2012-07-23 | 2014-01-30 | The Board Of Trustees Of The Leland Stanford Junior University | Methods for the treatment of cancer |
US11045454B2 (en) | 2018-12-06 | 2021-06-29 | Palo Alto Investors LP | Methods of treating food allergy conditions |
CN110776454B (en) * | 2019-12-10 | 2021-03-23 | 马宏跃 | Synthesis method of bufotenine and quaternary ammonium salt thereof and application of bufotenine and quaternary ammonium salt thereof in preparation of analgesic and anti-inflammatory drugs |
AU2021276656A1 (en) | 2020-05-19 | 2022-11-24 | Cybin Irl Limited | Deuterated tryptamine derivatives and methods of use |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0714663A3 (en) * | 1994-11-28 | 1997-01-15 | Lilly Co Eli | Potentiation of drug response by a serotonin 1A receptor antagonist |
DK1066036T3 (en) * | 1998-02-27 | 2006-08-21 | Univ Illinois | Agents with serotonin-related activity for the treatment of sleep apnea |
CN1461216A (en) * | 1999-04-28 | 2003-12-10 | 呼吸器有限公司 | Compound for use as medicament for treatment of disorders involving bronchocontraction |
GB9918425D0 (en) * | 1999-08-04 | 1999-10-06 | Novartis Ag | Organic compounds |
-
2001
- 2001-10-30 WO PCT/SE2001/002373 patent/WO2002036114A1/en not_active Application Discontinuation
- 2001-10-30 AU AU2002211176A patent/AU2002211176A1/en not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
WO2002036114A1 (en) | 2002-05-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4552099A (en) | Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5HT2 receptors | |
PL366233A1 (en) | Substituted pyridoindoles as serotonin agonists and antagonists | |
AU7429100A (en) | Chondrocyte compositions, preparation and use thereof | |
MXPA02007289A (en) | Novel melanocortin receptor agonists and antagonists. | |
AU2001243345A1 (en) | 1983, 52881, 2398, 45449, 50289, and 52872, g protein-coupled receptors and uses therefor | |
AU2002211176A1 (en) | Composition comprising serotonin receptor antagonists, 5 ht-2 and 5 ht-3 | |
AU2002234076A1 (en) | Construction composition, structure, and method | |
AU2001248279A1 (en) | New compounds, their preparation and use | |
MXPA03005257A (en) | Nmda receptor agonist pharmaceutical compositions. | |
HUP0200811A2 (en) | Solid composition, its producing and using | |
AU2002223501A1 (en) | Glucagon antagonists/inverse agonists | |
AU4217299A (en) | Pth1r and pth3r receptors, methods and uses thereof | |
AU2001264657A1 (en) | Crf receptor antagonists | |
AU2002223500A1 (en) | Glucagon antagonists/inverse agonists | |
EP1453503A4 (en) | Ep4 receptor agonist, compositions and methods thereof | |
ZA200100978B (en) | Muscarinic agonists and antagonists. | |
AU2002212888A1 (en) | Composition comprising: serotonin receptor antagonists (5ht-2, 5ht-3) and agonist (5ht-4) | |
AUPP380498A0 (en) | Egf receptor agonists and antagonists | |
HK1052511A1 (en) | Estrogen agonist/antagonist metabolites. | |
AU2001290772A1 (en) | Alpha v integrin receptor antagonists | |
GB0026467D0 (en) | Compound, composition and use | |
AU2001286409A1 (en) | N-methyl-d-aspartate receptor antagonists | |
HUP0100926A3 (en) | Benzylpiperazinyl- and benzylpiperidinyl ethanone derivatives, their preparation and their use as dopamine d4 receptor antagonists | |
AU8177801A (en) | 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists | |
AU1652601A (en) | New combination comprising a beta2-adrenoreceptor agonist and a leukotriene receptor antagonist |